Research within the Division of Hematology/Oncology includes programs at the forefront of clinical, translational and basic science investigation. Our clinical research activities are lead by world-renowned faculty members developing innovative protocols and driving the standard of care in the treatment of cancer and other hematological diseases. Translational research is ongoing in many laboratories developing novel agents and strategies to address the clinically relevant issues with the goal of impacting patient care and disease management. A group of internationally-recognized faculty leads the basic science research program within the division. Their labs are involved in generating new knowledge that will expand our understanding of cellular processes critical in hematology and oncology. Information about our basic science and clinical research programs is available on this site.